Nano-X Imaging (NASDAQ:NNOX) Earns “Buy” Rating from D. Boral Capital

Nano-X Imaging (NASDAQ:NNOX)‘s stock had its “buy” rating reiterated by stock analysts at D. Boral Capital in a report issued on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. D. Boral Capital’s target price points to a potential upside of 75.44% from the company’s previous close.

Several other research firms have also recently issued reports on NNOX. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Friday, April 10th. Cantor Fitzgerald upgraded Nano-X Imaging to a “strong-buy” rating in a report on Wednesday, March 4th. Three investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $5.00.

Nano-X Imaging Price Performance

NNOX opened at $2.85 on Monday. Nano-X Imaging has a 12 month low of $2.11 and a 12 month high of $5.86. The stock has a market capitalization of $186.33 million, a P/E ratio of -2.16 and a beta of 1.39. The business has a 50 day simple moving average of $2.44 and a 200-day simple moving average of $3.06.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of NNOX. AQR Capital Management LLC purchased a new stake in Nano-X Imaging in the first quarter valued at approximately $178,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Nano-X Imaging by 232.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock worth $10,793,000 after purchasing an additional 1,510,806 shares during the period. Geode Capital Management LLC raised its stake in Nano-X Imaging by 17.5% during the second quarter. Geode Capital Management LLC now owns 810,322 shares of the company’s stock worth $4,189,000 after purchasing an additional 120,460 shares during the period. Cetera Investment Advisers boosted its holdings in shares of Nano-X Imaging by 82.0% in the 2nd quarter. Cetera Investment Advisers now owns 48,056 shares of the company’s stock valued at $248,000 after purchasing an additional 21,657 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Nano-X Imaging by 61.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 65,783 shares of the company’s stock valued at $340,000 after buying an additional 25,048 shares during the period. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.